{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:00:45Z","timestamp":1789005645134,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011594","name":"Penn State College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020082","name":"Navarra Government General Directorate of Industry Energy and Strategic Projects S3","doi-asserted-by":"publisher","award":["207E\/2024"],"award-info":[{"award-number":["207E\/2024"]}],"id":[{"id":"10.13039\/501100020082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008321","name":"Pennsylvania State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018243","name":"Institute for Computational and Data Sciences, Pennsylvania State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011597","name":"Penn State Hershey Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011597","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118193","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T06:46:21Z","timestamp":1758696381000},"page":"118193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Synthesis and characterization of novel phenyl carboxamide-selenium analogs: Identification of a potent DHODH inhibitor as a potential anticancer agent"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3088-4751","authenticated-orcid":false,"given":"Cristina","family":"Mor\u00e1n-Serradilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3431-7826","authenticated-orcid":false,"given":"Carmen","family":"Sanmart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5716-7202","authenticated-orcid":false,"given":"Asif","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Aliaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8266-0445","authenticated-orcid":false,"given":"Daniel","family":"Plano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7679-7779","authenticated-orcid":false,"given":"Arun K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2025.118193_bib1","first-page":"229","article-title":"Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118193_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbcan.2010.06.001","article-title":"Targeting notch signaling pathway to overcome drug resistance for cancer therapy","volume":"1806","author":"Wang","year":"2010","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"10","key":"10.1016\/j.ejmech.2025.118193_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7287","article-title":"The double life of a chemotherapy drug: immunomodulatory functions of gemcitabine in cancer","volume":"13","author":"Larson","year":"2024","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118193_bib4","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.ejmech.2025.118193_bib5","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.3390\/molecules27217477","article-title":"Unveiling a new selenocyanate as a multitarget candidate with anticancer, antileishmanial and antibacterial potential","volume":"27","author":"Ramos-Inza","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.ejmech.2025.118193_bib6","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.3390\/molecules14093313","article-title":"Synthesis and pharmacological screening of several aroyl and heteroaroyl selenylacetic acid derivatives as cytotoxic and antiproliferative agents","volume":"14","author":"Sanmart\u00edn","year":"2009","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118193_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02200-18","article-title":"Synthesis and leishmanicidal activity of novel urea, thiourea, and selenourea derivatives of diselenides","volume":"63","author":"D\u00edaz","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118193_bib8","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1021\/acs.jmedchem.3c02426","article-title":"Selenization of small molecule drugs: a new player on the board","volume":"67","author":"Mor\u00e1n-Serradilla","year":"2024","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118193_bib9","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/acs.jmedchem.5b01503","article-title":"Design, synthesis, and biological evaluation of novel selenium (Se-nsaid) molecules as anticancer agents","volume":"59","author":"Plano","year":"2016","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118193_bib10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/molecules24081487","article-title":"Selenocompounds as novel antibacterial agents and bacterial efflux pump inhibitors","volume":"24","author":"Mosolyg\u00f3","year":"2019","journal-title":"Molecules"},{"issue":"15","key":"10.1016\/j.ejmech.2025.118193_bib11","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1039\/D3NJ05180C","article-title":"Selenium compounds as promising antiviral agents","volume":"48","author":"Jain","year":"2024","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2025.118193_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.abb.2015.06.024","article-title":"Selenoproteins: antioxidant selenoenzymes and beyond","volume":"595","author":"Steinbrenner","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"issue":"15","key":"10.1016\/j.ejmech.2025.118193_bib13","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.2174\/0929867320666131119121108","article-title":"Biological implications of selenium and its role in trypanosomiasis treatment","volume":"21","author":"da Silva","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00436-021-07400-8","article-title":"Selenium and Protozoan parasitic infections: selenocompounds and selenoproteins potential","volume":"121","author":"Rashidi","year":"2022","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2025.118193_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115002","article-title":"Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases","volume":"246","author":"Henriquez-Figuereo","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118193_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2018.05.001","article-title":"Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment","volume":"127","author":"Gandin","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.118193_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113384","article-title":"New organoselenides (Nsaids-Se derivatives) as potential anticancer agents: synthesis, biological evaluation and in silico calculations","volume":"218","author":"He","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118193_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112864","article-title":"Synthesis and biological evaluation of organoselenium (Nsaids-Secn and Secf3) derivatives as potential anticancer agents","volume":"208","author":"He","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118193_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02546-16","article-title":"Library of seleno-compounds as novel agents against Leishmania species","volume":"61","author":"Mart\u00edn-Montes","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118193_bib20","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3390\/molecules28041654","article-title":"(S)-N-Benzyl-1-Phenyl-3,4-Dihydroisoqunoline-2(1h)-Carboxamide derivatives, multi-target inhibitors of monoamine oxidase and cholinesterase: design, synthesis, and biological activity","volume":"28","author":"Jin","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118193_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.669728","article-title":"Benzohydrazide and phenylacetamide scaffolds: new putative pare inhibitors","volume":"9","author":"Yele","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.118193_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.130070","article-title":"Development of 3-Indolyl substituted phenyl Pyrazolo-carboxamide Hybrids as potential type ii Vegfr-2 inhibitors and in vitro cytotoxicity studies","volume":"117","author":"Valapil","year":"2025","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"11","key":"10.1016\/j.ejmech.2025.118193_bib23","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0149-2918(00)86732-6","article-title":"Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis","volume":"21","author":"Goldenberg","year":"1999","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib24","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1038\/s41598-019-42595-y","article-title":"Design and synthesis of anticancer 1-hydroxynaphthalene-2-carboxanilides with a P53 independent mechanism of action","volume":"9","author":"Spaczy\u0144ska","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13065-022-00839-5","article-title":"Synthesis of novel isoxazole-carboxamide derivatives as promising agents for melanoma and targeted nano-emulgel conjugate for improved cellular permeability","volume":"16","author":"Hawash","year":"2022","journal-title":"BMC Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118193_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416116","article-title":"Niclosamide as a promising therapeutic player in human cancer and other diseases","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118193_bib27","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/106002809002400612","article-title":"Flutamide: an antiandrogen for advanced prostate cancer","volume":"24","author":"Goldspiel","year":"1990","journal-title":"Dicp."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118193_bib28","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1200\/JCO.1997.15.8.2928","article-title":"Bicalutamide for advanced prostate cancer: the natural versus treated history of disease","volume":"15","author":"Scher","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118193_bib29","first-page":"741","article-title":"Trametinib: a targeted therapy in metastatic melanoma","volume":"9","author":"Hoffner","year":"2018","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.ejmech.2025.118193_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2018.10.012","article-title":"Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer","volume":"195","author":"Madak","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib31","article-title":"A novel and potent dihydroorotate dehydrogenase inhibitor suppresses the proliferation of colorectal cancer by inducing mitochondrial dysfunction and DNA damage","volume":"1","author":"Yang","year":"2022","journal-title":"MedComm. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40170-021-00250-z","article-title":"Dhodh and cancer: promising prospects to Be explored","volume":"9","author":"Zhou","year":"2021","journal-title":"Cancer Metabol."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118193_bib33","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41375-019-0461-5","article-title":"The novel dihydroorotate dehydrogenase (dhodh) inhibitor bay 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies","volume":"33","author":"Christian","year":"2019","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.ejmech.2025.118193_bib34","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41388-024-03005-4","article-title":"Dhodh inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer","volume":"43","author":"Guo","year":"2024","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118193_bib35","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1016\/j.ejmech.2011.04.054","article-title":"Selenocyanates and diselenides: a new class of potent antileishmanial agents","volume":"46","author":"Plano","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118193_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106624","article-title":"Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity","volume":"138","author":"Henriquez-Figuereo","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118193_bib37","article-title":"Insights on the functional dualism of nitric oxide in the hallmarks of cancer","volume":"1878","author":"Panneerselvan","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"9","key":"10.1016\/j.ejmech.2025.118193_bib38","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.21873\/anticanres.17204","article-title":"Novel diclofenac-No donor with high affinity for human serum albumin induces endoplasmic reticulum stress-mediated cell death in human pancreatic cancer cells","volume":"44","author":"Nishi","year":"2024","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/biomedicines11010199","article-title":"New nitric oxide-releasing compounds as promising anti-bladder cancer drugs","volume":"11","author":"Varela","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118193_bib40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/pr10050800","article-title":"Nitric oxide-releasing No\u2013curcumin hybrid inhibits colon cancer cell proliferation and induces cell death in vitro","volume":"10","author":"Hidmi","year":"2022","journal-title":"Processes"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118193_bib41","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1021\/acs.jnatprod.4c00084","article-title":"Discovery of cytotoxic nitric oxide-releasing piperlongumine derivatives targeting Wnt\/\u0392-catenin in colon cancer cells","volume":"87","author":"Zou","year":"2024","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118193_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107733","article-title":"Design, synthesis and biological evaluation of artesunate-Se derivatives as anticancer agents by inducing Gpx4-mediated ferroptosis","volume":"152","author":"Ren","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2025.118193_bib43","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1002\/cmdc.202100451","article-title":"Synthesis and biological evaluation of Cf(3) Se-substituted \u0391-amino acid derivatives","volume":"16","author":"Han","year":"2021","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118193_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.ejmech.2025.118193_bib45","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.3390\/molecules28155845","article-title":"Exploring novel drug combinations: the therapeutic potential of selanyl derivatives for leishmania treatment","volume":"28","author":"Henriquez-Figuereo","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118193_bib46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/microorganisms8040566","article-title":"Biofilm eradication by symmetrical selenoesters for food-borne pathogens","volume":"8","author":"Nov\u00e9","year":"2020","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118193_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1248\/cpb.60.465","article-title":"No-nsaids. Part 3: nitric oxide-releasing prodrugs of non-steroidal anti-inflammatory drugs","volume":"60","author":"Borhade","year":"2012","journal-title":"Chem. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118193_bib48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1039\/P29760000402","article-title":"13c nuclear magnetic resonance studies of some fluorinated and trifluoromethylated aromatic compounds. Studies on 13c\u201319f coupling constants","volume":"2","author":"Doddrell","year":"1976","journal-title":"J. Chem. Soc. Perkin. Trans."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/antiox9010055","article-title":"Novel N,N\u2032-Disubstituted acylselenoureas as potential antioxidant and cytotoxic agents","volume":"9","author":"Ruberte","year":"2020","journal-title":"Antioxidants"},{"issue":"17","key":"10.1016\/j.ejmech.2025.118193_bib50","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1016\/j.bmcl.2017.07.033","article-title":"Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid","volume":"27","author":"Gu","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.118193_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2021.132426","article-title":"Efficient one-pot tandem synthesis and cytotoxicity evaluation of 2,3-disubstituted quinazolin-4(3h)-one derivatives","volume":"98","author":"Bui","year":"2021","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.118193_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138869","article-title":"Design, synthesis and apoptotic activity of substituted chalcones tethered 1,3,5-triazine hybrids: an insights from molecular docking, molecular dynamics simulations, dft, adme, and dapi analyses","volume":"1315","author":"Gariganti","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118193_bib53","first-page":"A3.B.1","article-title":"Trypan blue exclusion test of cell viability","volume":"111","author":"Strober","year":"2015","journal-title":"Curr. Protoc. Im."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R","article-title":"Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure","volume":"31","author":"van Engeland","year":"1998","journal-title":"Cytometry"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biocel.2009.09.013","article-title":"Caspase-7: a protease involved in apoptosis and inflammation","volume":"42","author":"Lamkanfi","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118193_bib56","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"P53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ejmech.2025.118193_bib57","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/cas.13792","article-title":"Tumor suppressive role for kinases phosphorylating P53 in DNA damage-induced apoptosis","volume":"109","author":"Yogosawa","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2025.118193_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109196","article-title":"Natural products derived steroids as potential anti-leishmanial agents; disease prevalence, underlying mechanisms and future perspectives","volume":"193","author":"Elawad","year":"2023","journal-title":"Steroids"},{"issue":"7","key":"10.1016\/j.ejmech.2025.118193_bib59","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/metabo13070796","article-title":"Cancer metabolism: the role of ros in DNA damage and induction of apoptosis in cancer cells","volume":"13","author":"Zhao","year":"2023","journal-title":"Metabolites"},{"issue":"19","key":"10.1016\/j.ejmech.2025.118193_bib60","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1093\/emboj\/16.19.6008","article-title":"Induced N- and C-terminal cleavage of P53: a core fragment of P53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length P53, whereas ssdna induces C-terminal cleavage of P53","volume":"16","author":"Okorokov","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.118193_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dnarep.2018.07.008","article-title":"Multiple functions of P27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: a double-edged sword protein","volume":"69","author":"Abbastabar","year":"2018","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejmech.2025.118193_bib62","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3389\/fonc.2020.01195","article-title":"Multi-omics characterization of the 4t1 murine mammary gland tumor model","volume":"10","author":"Schr\u00f6rs","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.118193_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.imlet.2017.11.010","article-title":"Inhibition of tumor growth by mouse Ror1 specific antibody in a syngeneic mouse tumor model","volume":"193","author":"Hassannia","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ejmech.2025.118193_bib64","first-page":"20","article-title":"Mouse 4t1 breast tumor model","volume":"20","author":"Pulaski","year":"2001","journal-title":"Curr. Protoc. Im."},{"issue":"W1","key":"10.1016\/j.ejmech.2025.118193_bib65","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"Admetlab 3.0: an updated comprehensive online admet prediction platform enhanced with broader coverage, improved performance, api functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118193_bib66","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"Pkcsm: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118193_bib67","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejmech.2012.03.026","article-title":"Synthesis, evaluation of anticancer activity and compare analysis of N-Bis(Trifluoromethyl)Alkyl-N\u2019-Substituted ureas with pharmacophoric moieties","volume":"53","author":"Luzina","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.32607\/20758251-2014-6-1-69-75","article-title":"The role of dihydroorotate dehydrogenase in apoptosis induction in response to inhibition of the mitochondrial respiratory chain complex iii","volume":"6","author":"Khutornenko","year":"2014","journal-title":"Acta Nat."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00418-024-02339-0","article-title":"Mechanisms of S-phase arrest and mitochondrial dysfunction in complex iii by dhodh inhibitors in tumorigenic tnbc cells","volume":"163","author":"Shahhiran","year":"2024","journal-title":"Histochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118193_bib70","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"Olex2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Crystallogr."},{"issue":"Pt 1","key":"10.1016\/j.ejmech.2025.118193_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"Shelxt - integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. A Found Adv."},{"issue":"Pt 1","key":"10.1016\/j.ejmech.2025.118193_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with shelxl","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C Struct Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118193_bib73","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6807-11-6","article-title":"Graphical analysis of Ph-dependent properties of proteins predicted using propka","volume":"11","author":"Rostkowski","year":"2011","journal-title":"BMC Struct. Biol."},{"issue":"20","key":"10.1016\/j.ejmech.2025.118193_bib74","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.3390\/cancers16203502","article-title":"Rna binding proteins as potential therapeutic targets in colorectal cancer","volume":"16","author":"Singh","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118193_bib75","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1063\/1.463940","article-title":"Nos\u00e9\u2013hoover chains: the canonical ensemble via continuous dynamics","volume":"97","author":"Martyna","year":"1992","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118193_bib76","unstructured":"Nci-60 Screening Methodology. https:\/\/dtp.cancer.gov\/discovery_development\/nci-60\/methodology.htm (accessed 2024 14\/06)."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118193_bib77","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.1432-1327.2001.02061.x","article-title":"Recombinant expression of N-terminal truncated mutants of the membrane bound mouse, rat and human flavoenzyme dihydroorotate dehydrogenase","volume":"268","author":"Ullrich","year":"2001","journal-title":"Eur. J. Biochem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:58:40Z","timestamp":1773133120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":77,"alternative-id":["S0223523425009584"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118193","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and characterization of novel phenyl carboxamide-selenium analogs: Identification of a potent DHODH inhibitor as a potential anticancer agent","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118193"}}